Supreme Court: Registered Sale Deed Carries Strong Presumption of Genuineness || SC: Registry Cannot Intrude Into Judiciary’s Exclusive Domain By Questioning Why a Party is Impleaded || Calcutta HC: Third-Party Suits in a Deity’s Name are Allowed Only When The Sebait Loses Authority || Madras HC: Encroachment on a Public Street Cannot be Allowed Even If It Has a Religious Character || Karnataka HC: Bike Taxi Business Protected under Article 19(1)(G); State Can Regulate But Not Ban || Allahabad HC: Not Specifying Arrest Grounds in Memo is Dereliction; Erring Cops Must be Suspended || Del. HC Stresses Mandatory Legal Assistance to Preserve Fairness and Integrity of Criminal Trials || Supreme Court: Delhi High Court Ruling upheld on Taekwondo National Sports Federation Recognition || SC: Blockchain-Based Digitisation of Land Records Necessary to Reduce Property Document Litigation || Supreme Court to NCLT : Limit Power to Decide Intellectual Property Title Disputes under IBC

Drugs and Cosmetics (Amendment) Bill, 2015 - (30 Nov 2015)

Miscellaneous

The Drugs and Cosmetics (Amendment) Bill, 2015, set to be introduced in the Parliament’s Winter Session, 2015, proposes much needed updates to the Drugs and Cosmetics Act, 1940. The Bill, 2015 broadens the scope of the government’s powers and introduces checks and balances in the manufacture, import, distribution and sale of drugs and cosmetics in India. Clinical trials are set to be overseen by the Ethics Committee, constituted under the Bill. The Committee will also have powers to audit clinical trials and make site visits to ensure safety and well being of participants. Greater regulation and oversight, stricter punishments and vigilance outline the proactive stance the Bill proposes for the government.

Tags : DRUG AND COSMETICS BILL 2015 ETHICS COMMITTEE

Share :